Pharmac Review

On 2 March 2021 the Government announced that it had commissioned a review of the Pharmaceutical Management Agency, known as PHARMAC.

The Review will focus on two areas:

  • how well PHARMAC performs against its current objectives and whether and how its performance against these could be improved
  • whether PHARMAC’s current objectives maximise its potential to improve health outcomes for all New Zealanders as part of the wider health system, and whether and how these objectives should be changed

and will consider a range of factors, including:

  • the timeliness of PHARMAC’s decision making (in particular for new medicines)
  • the transparency and accessibility of decision-making processes
  • equity, including access to medicines and devices for Māori and Pacific peoples.

Do you or someone you know have Fabry Disease?

We're always looking to connect with families who are affected by Fabry disease so that we can share experiences, information, and support where possible.

Get in touch today

News & Updates

Fabry Gene Therapy Trial

The Medicine Gap

Rare Disorder Framework pushed back